Lithium hydroxide

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Lithium hydroxide
Accession Number
DB14506
Type
Small Molecule
Groups
Approved, Experimental
Description

Used for tryptophan determinations in proteins & foods.

Structure
Thumb
Synonyms
  • Lithium hydrate
  • Lithium hydroxide anhydrous
  • Lithiumhydroxid
Product Ingredients
IngredientUNIICASInChI Key
Lithium hydroxide monohydrateG51XLP968G1310-66-3GLXDVVHUTZTUQK-UHFFFAOYSA-M
Active Moieties
NameKindUNIICASInChI Key
Lithium cationionic8H8Z5UER667439-93-2HBBGRARXTFLTSG-UHFFFAOYSA-N
Generic Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Lithium Hydroxide MonohydrateSolution8 meq/5mLOralMorton Grove Pharmaceuticals, Inc.1986-05-212011-04-06Us
Categories
UNII
903YL31JAS
CAS number
1310-65-2
Weight
Average: 23.95
Monoisotopic: 24.01874309
Chemical Formula
HLiO
InChI Key
WMFOQBRAJBCJND-UHFFFAOYSA-M
InChI
InChI=1S/Li.H2O/h;1H2/q+1;/p-1
IUPAC Name
lithium(1+) hydroxide
SMILES
[Li+].[OH-]

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
AbacavirAbacavir may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AcarboseAcarbose may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AceclofenacAceclofenac may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AcemetacinAcemetacin may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AcetaminophenAcetaminophen may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AcetazolamideAcetazolamide may increase the excretion rate of Lithium hydroxide which could result in a lower serum level and potentially a reduction in efficacy.
Acetylsalicylic acidAcetylsalicylic acid may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AclidiniumAclidinium may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AcrivastineAcrivastine may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AcyclovirAcyclovir may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
Food Interactions
Not Available

References

General References
Not Available
External Links
ChemSpider
3802
ChEBI
33979
Wikipedia
Lithium_hydroxide

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
SolutionOral8 meq/5mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP0ChemAxon
pKa (Strongest Acidic)3.09ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area0 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity0 m3·mol-1ChemAxon
Polarizability1.78 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on July 11, 2018 15:53 / Updated on December 14, 2018 05:48